Status:
RECRUITING
Spastic Paraplegia - Centers of Excellence Research Network
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Massachusetts General Hospital
Columbia University
Conditions:
Hereditary Spastic Paraplegia
Primary Lateral Sclerosis
Eligibility:
All Genders
Brief Summary
The Spastic Paraplegia - Centers of Excellence Research Network (SP-CERN) is a collaborative research consortium dedicated to advancing the understanding, diagnosis, and treatment of hereditary spasti...
Detailed Description
The hereditary spastic paraplegias (HSPs) include over 80 rare neurogenetic disorders, collectively representing the most prevalent cause of inherited spasticity and related disabilities globally. In ...
Eligibility Criteria
Inclusion
- Male or female patients of all ages with a clinical and molecular diagnosis of hereditary spastic paraplegia type 4 (SPG4, SPAST) or hereditary spastic paraplegia type 5A (SPG5A, CYP7B1).
Exclusion
- Not having such a diagnosis and/or not being related to such individual.
Key Trial Info
Start Date :
June 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 4 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06553976
Start Date
June 4 2024
End Date
June 4 2027
Last Update
December 13 2024
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
2
University of Iowa Carver College of Medicine
Iowa City, Iowa, United States, 52242
3
Boston Children's Hospital
Boston, Massachusetts, United States, 02215
4
Massachusetts General Hospital
Boston, Massachusetts, United States, 02215